These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 17048488)

  • 41. Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach.
    Lokras A; Foged C; Thakur A
    Methods Mol Biol; 2021; 2282():137-157. PubMed ID: 33928574
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Poly(lactide-
    Wu L; Wu LP; Wu J; Sun J; He Z; Rodríguez-Rodríguez C; Saatchi K; Dailey LA; Häfeli UO; Cun D; Yang M
    ACS Appl Mater Interfaces; 2021 Jan; 13(3):3722-3737. PubMed ID: 33439616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EGFP-EGF1-conjugated PLGA nanoparticles for targeted delivery of siRNA into injured brain microvascular endothelial cells for efficient RNA interference.
    Chen C; Mei H; Shi W; Deng J; Zhang B; Guo T; Wang H; Hu Y
    PLoS One; 2013; 8(4):e60860. PubMed ID: 23593330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymeric nanoparticles of siRNA prepared by a double-emulsion solvent-diffusion technique: Physicochemical properties, toxicity, biodistribution and efficacy in a mammary carcinoma mice model.
    Ben David-Naim M; Grad E; Aizik G; Nordling-David MM; Moshel O; Granot Z; Golomb G
    Biomaterials; 2017 Nov; 145():154-167. PubMed ID: 28863309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanistic profiling of the siRNA delivery dynamics of lipid-polymer hybrid nanoparticles.
    Colombo S; Cun D; Remaut K; Bunker M; Zhang J; Martin-Bertelsen B; Yaghmur A; Braeckmans K; Nielsen HM; Foged C
    J Control Release; 2015 Mar; 201():22-31. PubMed ID: 25540904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
    Heo MB; Cho MY; Lim YT
    Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation and Evaluation of Chrysin Encapsulated in PLGA- PEG Nanoparticles in the T47-D Breast Cancer Cell Line.
    Mohammadinejad S; Akbarzadeh A; Rahmati-Yamchi M; Hatam S; Kachalaki S; Zohreh S; Zarghami N
    Asian Pac J Cancer Prev; 2015; 16(9):3753-8. PubMed ID: 25987033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
    Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
    Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In situ micro-sized gel-forming injectable implant using biodegradable amphiphilic graft copolymer.
    Cho KY; Lee S; Park JK
    Macromol Biosci; 2007 Jun; 7(6):784-8. PubMed ID: 17541923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
    Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of multiple-layer polymeric particles for targeted and controlled drug delivery.
    Koppolu B; Rahimi M; Nattama S; Wadajkar A; Nguyen KT
    Nanomedicine; 2010 Apr; 6(2):355-61. PubMed ID: 19699325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Local delivery of siRNA-loaded calcium phosphate nanoparticles abates pulmonary inflammation.
    Frede A; Neuhaus B; Knuschke T; Wadwa M; Kollenda S; Klopfleisch R; Hansen W; Buer J; Bruder D; Epple M; Westendorf AM
    Nanomedicine; 2017 Nov; 13(8):2395-2403. PubMed ID: 28800875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Self-assembled siRNA-PLGA conjugate micelles for gene silencing.
    Lee SH; Mok H; Lee Y; Park TG
    J Control Release; 2011 May; 152(1):152-8. PubMed ID: 21185893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biodegradable Film for the Targeted Delivery of siRNA-Loaded Nanoparticles to Vaginal Immune Cells.
    Gu J; Yang S; Ho EA
    Mol Pharm; 2015 Aug; 12(8):2889-903. PubMed ID: 26099315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of drug delivery and anticancer potentials of nanoparticles-loaded siRNA targeting STAT3 in lung cancer, in vitro and in vivo.
    Das J; Das S; Paul A; Samadder A; Bhattacharyya SS; Khuda-Bukhsh AR
    Toxicol Lett; 2014 Mar; 225(3):454-66. PubMed ID: 24440344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Theranostic poly(lactic-co-glycolic acid) nanoparticle for magnetic resonance/infrared fluorescence bimodal imaging and efficient siRNA delivery to macrophages and its evaluation in a kidney injury model.
    Yang C; Vu-Quang H; Husum DMU; Tingskov SJ; Vinding MS; Nielsen T; Song P; Nielsen NC; Nørregaard R; Kjems J
    Nanomedicine; 2017 Nov; 13(8):2451-2462. PubMed ID: 28842376
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles.
    Benfer M; Kissel T
    Eur J Pharm Biopharm; 2012 Feb; 80(2):247-56. PubMed ID: 22085653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tailoring Lipid and Polymeric Nanoparticles as siRNA Carriers towards the Blood-Brain Barrier - from Targeting to Safe Administration.
    Gomes MJ; Fernandes C; Martins S; Borges F; Sarmento B
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):107-119. PubMed ID: 27209050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Co-delivery of Cbfa-1-targeting siRNA and SOX9 protein using PLGA nanoparticles to induce chondrogenesis of human mesenchymal stem cells.
    Jeon SY; Park JS; Yang HN; Lim HJ; Yi SW; Park H; Park KH
    Biomaterials; 2014 Sep; 35(28):8236-48. PubMed ID: 24965885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
    Derakhshandeh K; Erfan M; Dadashzadeh S
    Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.